. . "A sulfanilamide that is used as an antibacterial agent. It can be used to treat bronchitis, prostatitis and urinary tract infections."@en . . . . "Sulfamerazine is a sulfonamide drug that inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA) for binding to dihydropteroate synthetase (dihydrofolate synthetase). Sulfamerazine is bacteriostatic in nature. Inhibition of dihydrofolic acid synthesis decreases the synthesis of bacterial nucleotides and DNA. "@en . "Do not take calcium, aluminium, magnesium or iron supplements within 2 hours of taking this medication."@en . . "approved"@en . . . "127-79-7"@en . . "2-(4-Aminobenzenesulfonamido)-4-methylpyrimidine"@en . . . . . "2-(P-Aminobenzolsulfonamido)-4-methylpyrimidine"@en . . . "2-(Sulfanilamido)-4-methylpyrimidine"@en . "Sulfamerazine may cause nausea, vomiting, diarrhea and hypersensitivity reactions. Hematologic effects such as anemia, agranulocytosis, thrombocytopenia and hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency may also occur. Sulfamethoxazole may displace bilirubin from albumin binding sites causing jaundice or kernicterus in newborns. "@en . . . "Sulfamerazina"@en . "4-Amino-N-(4-methyl-2-pyrimidinyl)-benzenesulfonamide"@en . . . "N-(4-Methyl-2-pyrimidyl)sulfanilamide"@en . . . . . . . . "A sulfanilamide that is used as an antibacterial agent. [PubChem]"@en . . " "@en . . . . . . . . "(P-Aminobenzolsulfonyl)-2-amino-4-methylpyrimidin"@en . . . . "Sulfamerazinum"@en . "Rapidly absorbed following oral administration."@en . "Sulfamerazine"@en . . . . . "Sulfamethyldiazine"@en . "2-Sulfa-4-methylpyrimidine"@en . "Sulphamerazine"@en . "N(1)-(4-Methyl-2-pyrimidinyl)sulfanilamide"@en .